1. Home
  2. MDXH vs BWG Comparison

MDXH vs BWG Comparison

Compare MDXH & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • BWG
  • Stock Information
  • Founded
  • MDXH 2003
  • BWG 2012
  • Country
  • MDXH Belgium
  • BWG United States
  • Employees
  • MDXH N/A
  • BWG N/A
  • Industry
  • MDXH
  • BWG Finance/Investors Services
  • Sector
  • MDXH
  • BWG Finance
  • Exchange
  • MDXH Nasdaq
  • BWG Nasdaq
  • Market Cap
  • MDXH 141.1M
  • BWG 142.7M
  • IPO Year
  • MDXH 2021
  • BWG N/A
  • Fundamental
  • Price
  • MDXH $3.55
  • BWG $8.62
  • Analyst Decision
  • MDXH Buy
  • BWG
  • Analyst Count
  • MDXH 1
  • BWG 0
  • Target Price
  • MDXH $6.00
  • BWG N/A
  • AVG Volume (30 Days)
  • MDXH 172.3K
  • BWG 53.8K
  • Earning Date
  • MDXH 08-05-2025
  • BWG 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • BWG 11.37%
  • EPS Growth
  • MDXH N/A
  • BWG N/A
  • EPS
  • MDXH N/A
  • BWG N/A
  • Revenue
  • MDXH $98,953,000.00
  • BWG N/A
  • Revenue This Year
  • MDXH $24.77
  • BWG N/A
  • Revenue Next Year
  • MDXH $22.21
  • BWG N/A
  • P/E Ratio
  • MDXH N/A
  • BWG N/A
  • Revenue Growth
  • MDXH 22.56
  • BWG N/A
  • 52 Week Low
  • MDXH $1.35
  • BWG $6.86
  • 52 Week High
  • MDXH $3.81
  • BWG $8.65
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 73.83
  • BWG 57.55
  • Support Level
  • MDXH $2.86
  • BWG $8.54
  • Resistance Level
  • MDXH $3.81
  • BWG $8.67
  • Average True Range (ATR)
  • MDXH 0.22
  • BWG 0.07
  • MACD
  • MDXH 0.05
  • BWG -0.01
  • Stochastic Oscillator
  • MDXH 78.15
  • BWG 66.67

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.

BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.

Share on Social Networks: